Last Posted: Jan 07, 2019
- Genetic testing does not cause undue worry for breast cancer patients
University of Michigan, January 4, 2019 - https://www.cancer.gov/news-events/cancer-currents-blog/2019/early-stage-lung-cancer-biomarker
NCI, January 3, 2019 - Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms
G Riedlinger et al, JAMA Oncology, January 3, 2019 - The Race to Diagnose Cancer With a Simple Blood Test-Liquid biopsies could transform cancer care as we know it
R Winslow, Medium, January 3, 2019 - [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W et al. Zhonghua fu chan ke za zhi 2018 Dec 53(12) 823-830 - 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer.
Chen Xiang-Hong et al. Biomarkers in medicine 2018 Dec - Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank.
Olson Janet E et al. Mayo Clinic proceedings. Innovations, quality & outcomes 2018 Dec 2(4) 352-358 - BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
Cline Melissa S et al. PLoS genetics 2018 Dec 14(12) e1007752 - Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment.
Campbell Aideen M et al. BMJ open 2018 Dec 8(12) e023115 - Cost-Effective But Unaffordable: The CAR-T Conundrum.
Leech Ashley A et al. Journal of the National Cancer Institute 2018 Dec
.png)
No hay comentarios:
Publicar un comentario